Samsung Bioepis Humira biosimilar wins FDA approval
(This story corrects to show that Hadlima belongs to Samsung Bioepis not Merck & Co Inc, which is commercializing the drug in the United States)
from Reuters: Health News https://reut.rs/2Yg3Zuz
http://bit.ly/2zwRqiM